Organ Transplant Immunosuppressant Market 2021 Organ Transplant Immunosuppressant Market 2021

Organ Transplant Immunosuppressant
Market is Projected to Grow at a CAGR of
3.81% during 2017-2021: Radiant Insights,
Inc
“The report covers the present scenario and the
growth prospects of the global organ transplant
immunosuppressant market for 2017-2021. To
calculate the market size, the report considers the
sales of both branded and generic drugs.”
About Organ Transplant Immunosuppressant
An organ transplantation is a surgical procedure that involves replacing diseased organs such as a
heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor
(who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung
transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report,
the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas,
and intestine. On any given day, there are about 75,000 people on active waiting list for organ
transplantation. However, the organ donors are very few, leading to the high unmet need for organ
availability. There are only 8,000 deceased organ donors annually, with each providing on average
3.5 organs. Living donors provide on average only around 6,000 organs per year.
View summary of this report @ http://www.radiantinsights.com/research/global-organ-
transplant-immunosuppressant-market-2017-2021
Follow Us: